The Clinical Psychopharmacology Section conducts preclinical and clinical research into the mechanisms of action of cocaine. A major component of this project, conducted in collaboration with investigators at NIDDK AND NIMH, is the synthesis and evaluation of analogs of GBR12909 as putative cocaine antagonists. The initial phase of this project has identified several promising novel agents, including the most selective dopamine uptake inhibitor reported. Another component involves investigation of the possible heterogeneity of DA transporter binding sites. This project has identified multiple binding sites for [3H]GBR12935 and [3H]BTCP, and a single binding site for [3H]mazindol. Another component of this project addresses the role of classical conditioning in cocaine-induced behavioral sensitization. These studies have demonstrated that associative learning mechanisms are involved in the acquisition of context-specific behavioral sensitization to cocaine. Another component of this project tested the leading theory of cocaine addiction, which supposes that chronic cocaine use depletes brain dopamine ' Chronic cocaine did not significantly alter the basal levels of DA or 5-HT, or the rate of L-DOPA or 5-HTP accumulation in any region. However, in chronic cocaine-treated rats, the inhibitory effect of cocaine on DA and 5-HT synthesis was greatly reduced. These data suggest that the compensatory feedback mechanisms regulating biogenic amine synthesis are desensitized by repeated cocaine injections. Clinical protocols, currently underway, 1) test the DA hypothesis of cocaine addiction by acute administration of cocaine to subjects who are on various DA receptor antagonists (ARC-170); and 2) attempt to develop a human model of context-specific behavioral sensitization to cocaine (ARC-174). The significance of these findings to drug abuse research is that increased understanding of how cocaine works will lead to the development of improved treatments.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Intramural Research (Z01)
Project #
1Z01DA000119-01
Application #
3838616
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
National Institute on Drug Abuse
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Hampson, Robert E; Collins, Vernell; Deadwyler, Sam A (2009) A wireless recording system that utilizes Bluetooth technology to transmit neural activity in freely moving animals. J Neurosci Methods 182:195-204
Hampson, R E; EspaƱa, R A; Rogers, G A et al. (2009) Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717. Psychopharmacology (Berl) 202:355-69
Rothman, Richard B; Baumann, Michael H (2009) Serotonergic drugs and valvular heart disease. Expert Opin Drug Saf 8:317-29
Rothman, Richard B; Baumann, Michael H (2009) Appetite suppressants, cardiac valve disease and combination pharmacotherapy. Am J Ther 16:354-64
Opris, I; Hampson, R E; Deadwyler, S A (2009) The encoding of cocaine vs. natural rewards in the striatum of nonhuman primates: categories with different activations. Neuroscience 163:40-54
Rothman, Richard B; Blough, Bruce E; Baumann, Michael H (2008) Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction. Exp Clin Psychopharmacol 16:458-74
Pariser, Joseph J; Partilla, John S; Dersch, Christina M et al. (2008) Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine release. J Pharmacol Exp Ther 326:286-95
Gilbert, Kathleen M; Boos, Terrence L; Dersch, Christina M et al. (2007) DAT/SERT selectivity of flexible GBR 12909 analogs modeled using 3D-QSAR methods. Bioorg Med Chem 15:1146-59
Rothman, Richard B; Blough, Bruce E; Baumann, Michael H (2007) Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions. AAPS J 9:E1-10
Wang, X; Baumann, M H; Dersch, C M et al. (2007) Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan. Neuroscience 148:212-20

Showing the most recent 10 out of 59 publications